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Peniston brings up some very important points that should be 
addressed. 
Regarding pulmonary vuscr&ar resisrance, we did not detail’the 
hemodynamic data on the patients undergoing heterotopic trans- 
plantation because of the small number of such patients. In each 
case, the preoperative pulmonary vascular resistance (without al- 
tetations by inotropic agents or afterload reduction) was 26 Wood 
units or the pulmonary artery systolic pressure was >70 mm Hg. In 
Figure 3, Peniston is correct in stating that the pulmonary vascular 
resistance data relate to 51 of the 63 patients. In each actuarial 
curve, the number of patients is indicated in parentheses. It is also 
specifically stated in the legend that 12 patients had no preoperative 
pulmonary vascular resistance data. Therefore, I do not believe the 
figure is misleading. In the multivariate analysis, patients with no 
available preoperative pulmonary vascular resistance data were 
assigned the mean value for the pulmonary vascular resistance 
among all other patients with data available. This is a standard 
statistical method, and one that we believe is sound. When the 
multivariate analysis was repeated to include only patients with 
pulmonary vascular resistance data, pulmonary vascular resistance 
continued to be a risk factor. 
Black me. As stated in our Discussion, the ihcremental risk of 
black race was perplexing, and we chose not to discuss this variable 
in any depth. This relates mainly to our Suspicion that, despite the 
multivariate analysis, the association between black race and lower 
late survival may not be supported by a larger data set. In fact, there 
were 8 black patients and 55 white patients; the actuarial survival at 
20 months was only about 30% for thC black patient group, whereas 
the white patients had an actuarial survival of approximately 60% at 
the same time interval. As Peniston suggests, our allusion to 
psychosocial and compliance factors may have been inappropriate, 
but it was based on several black patients who died at home from 
presumed rejection after a subacute illness without m&king appra- 
priate efforts to contact our insiitution. 
A subsequeht analysis of risk factors in a larger group of cardiac 
transplant patients at our institution undergoing transplantation 
through April 1987foiIed to show black race as a risk factor for early 
or late survival (Pulmonary vascular resistance and the risk of 
cardiac transplantation by Kirklin et al., Journal of Heart Trans- 
planrariun; in press). This inore current analysis indicates that 
pulmonary vascular resistance and congenital heart disease are the 
most significant risk factors for death tier cardiac transplantation. 
Therefore, our current belief, based on a more recent multivarl&e 
analysis with a larger patient population, is that black race is not a 
risk factor for death after cardiac transplantation. This obviously 
underscores one of the inherent weaknesses of multivariate analy- 
ses. Specifically, one is limited by the specific data set with which 
one is working. Ideally, multi-institutional studies (with the largest 
possible number of observations) would allow the closest approxi- 
mation of troth in a proper multivariate analysis of risk factors, 
Regarding rerronsplnnrarion, the results of retransplantation 
were not specifically addressed in this study. Rather, survival of 
each patient undergoing transplantation (with or without subsequent 
transplant procedures) was analyzed. Therefore, the results of 
retransplantation were included in the analysis but were not ana- 
lyzed separately. In fact, retransplantation was uniformly performed 
for acute cardiac decompensation, usually related to rejection. Only 
two of six such patients undergoing a secoqd transplantation were 
long-term survivors. 
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